No connection

Search Results

Corporate Score 30 Neutral

Eton Pharmaceuticals Appoints Judith Matthews as Chief Financial Officer

Apr 16, 2026 12:02 UTC
ETON
Short term

Eton Pharmaceuticals has named Judith M. Matthews as its new CFO, effective June 1. The appointment is part of a planned leadership transition as James Gruber steps down.

  • Judith Matthews appointed EVP of Accounting and Finance effective immediately
  • Official transition to CFO role scheduled for June 1, 2026
  • James Gruber to step down per planned succession
  • Matthews previously served as CFO of Iterum Therapeutics (2015-2026)
  • ETON shares closed at $26.97 on the previous trading day

Eton Pharmaceuticals Inc. (ETON) announced on Thursday the appointment of Judith M. Matthews as Executive Vice President of Accounting and Finance, effective immediately. This role serves as a transition period before Matthews officially assumes the position of Chief Financial Officer on June 1, 2026. Matthews succeeds James Gruber, who will step down from the CFO role as part of a structured and planned succession strategy. The company aims to ensure a seamless transition of financial leadership during this period. With over 25 years of experience in finance leadership, Matthews brings significant industry expertise to Eton. She most recently served as the Chief Financial Officer at Iterum Therapeutics plc, where she held the position from 2015 until 2026. Market reaction to the announcement has been muted. On Wednesday, shares of Eton Pharmaceuticals closed at $26.97, reflecting a slight decline of 0.55%. Investors typically view planned executive successions as stable corporate governance, though the long-term impact will depend on the new CFO's strategic execution.

Sign up free to read the full analysis

Create a free account to unlock full AI-curated market articles, personalized alerts, and more.

Share this article

Related Articles

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Home
Terminal
AI
Markets
Profile